Research ArticleConference Proceedings
Proceedings of the 2023 Viral Clearance Symposium, Session 1: Regulatory Updates
Thomas R. Kreil
PDA Journal of Pharmaceutical Science and Technology March 2024, 78 (2) 144-146; DOI: https://doi.org/10.5731/pdajpst.2024.002241
Thomas R. Kreil
Global Pathogen Safety, Takeda Manufacturing Austria AG, 1221 Vienna, Austria

Reference
- 1.↵
- Ma H.,
- Galvin T. A.,
- Glasner D. R.,
- Shaheduzzaman S.,
- Khan A. S.
In This Issue
PDA Journal of Pharmaceutical Science and Technology
Vol. 78, Issue 2
March/April 2024
Proceedings of the 2023 Viral Clearance Symposium, Session 1: Regulatory Updates
Thomas R. Kreil
PDA Journal of Pharmaceutical Science and Technology Mar 2024, 78 (2) 144-146; DOI: 10.5731/pdajpst.2024.002241
Jump to section
- Article
- Abstract
- Johannes Blümel, Virus Safety Section Paul-Ehrlich Institute
- Scott Lute, FDA/CDER/OPQ/OBP/DBRRII
- Marie Murphy, Eli Lilly, for the European Federation of Pharmaceutical Industries and Associations (EFPIA)
- David Roush, MSD, for Pharmaceutical Research and Manufacturers of America (PhRMA)
- Conflict of Interest Declaration
- Footnotes
- Reference
- References
- Info & Metrics
Related Articles
- No related articles found.
Cited By...
- No citing articles found.